No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
2 | Adherens junction 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
3 | Adipocytokine signaling pathway 2 genes, 4 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | African trypanosomiasis 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
5 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 4 drugs (DrugBank) and 23 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
6 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
7 | Aldosterone synthesis and secretion 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
8 | Allograft rejection 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Alzheimer disease 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Amoebiasis 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | AMPK signaling pathway 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
12 | Amyotrophic lateral sclerosis (ALS) 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
13 | Antifolate resistance 4 genes, 4 drugs (DrugBank) and 42 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
14 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Apelin signaling pathway 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
16 | Apoptosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
17 | Asthma 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
18 | Autophagy - animal 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
19 | Autophagy - other 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
20 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
21 | Bladder cancer 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
22 | Breast cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
23 | Butanoate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
24 | C-type lectin receptor signaling pathway 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
25 | Calcium signaling pathway 4 genes, 2 drugs (DrugBank) and 16 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
26 | Cellular senescence 2 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
27 | Central carbon metabolism in cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
28 | Chagas disease (American trypanosomiasis) 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
29 | Choline metabolism in cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
30 | Circadian entrainment 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
31 | Colorectal cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
32 | Cortisol synthesis and secretion 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
33 | Cushing syndrome 4 genes, 2 drugs (DrugBank) and 16 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
34 | Cytokine-cytokine receptor interaction 4 genes, 5 drugs (DrugBank) and 44 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
35 | Cytosolic DNA-sensing pathway 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
36 | Dilated cardiomyopathy (DCM) 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
37 | EGFR tyrosine kinase inhibitor resistance 5 genes, 7 drugs (DrugBank) and 49 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
38 | Endocrine resistance 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
39 | Endocytosis 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
40 | Endometrial cancer 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
41 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
42 | Epstein-Barr virus infection 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
43 | ErbB signaling pathway 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
44 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
45 | Fc epsilon RI signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
46 | Fluid shear stress and atherosclerosis 2 genes, 3 drugs (DrugBank) and 23 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
47 | Focal adhesion 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
48 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
49 | FoxO signaling pathway 2 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
50 | GABAergic synapse 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
51 | Gap junction 10 genes, 2 drugs (DrugBank) and 7 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
52 | Gastric cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
53 | Glioma 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
54 | GnRH secretion 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
55 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
56 | Graft-versus-host disease 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
57 | Growth hormone synthesis, secretion and action 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
58 | Hematopoietic cell lineage 5 genes, 6 drugs (DrugBank) and 63 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
59 | Hepatitis B 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
60 | Hepatitis C 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
61 | Hepatocellular carcinoma 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
62 | Herpes simplex virus 1 infection 3 genes, 5 drugs (DrugBank) and 46 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
63 | HIF-1 signaling pathway 5 genes, 7 drugs (DrugBank) and 49 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
64 | Human cytomegalovirus infection 6 genes, 8 drugs (DrugBank) and 55 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
65 | Human immunodeficiency virus 1 infection 2 genes, 4 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
66 | Human papillomavirus infection 4 genes, 6 drugs (DrugBank) and 47 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
67 | Human T-cell leukemia virus 1 infection 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
68 | Hypertrophic cardiomyopathy (HCM) 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
69 | IL-17 signaling pathway 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
70 | Inflammatory bowel disease (IBD) 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
71 | Influenza A 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
72 | Insulin resistance 3 genes, 5 drugs (DrugBank) and 46 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
73 | Insulin signaling pathway 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
74 | Intestinal immune network for IgA production 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
75 | JAK-STAT signaling pathway 5 genes, 7 drugs (DrugBank) and 57 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
76 | Kaposi sarcoma-associated herpesvirus infection 3 genes, 5 drugs (DrugBank) and 39 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
77 | Legionellosis 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Leishmaniasis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
79 | Longevity regulating pathway 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
80 | Longevity regulating pathway - multiple species 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
81 | Malaria 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
82 | MAPK signaling pathway 6 genes, 5 drugs (DrugBank) and 32 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
83 | Measles 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
84 | Melanoma 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
85 | Metabolic pathways 6 genes, 2 drugs (DrugBank) and 43 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
86 | MicroRNAs in cancer 3 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
87 | mTOR signaling pathway 2 genes, 4 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
88 | Natural killer cell mediated cytotoxicity 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | Necroptosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
90 | Neuroactive ligand-receptor interaction 1 gene, 1 drug (DrugBank) and 44 diseases shown |
1件: NR3C1 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
91 | NF-kappa B signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
92 | NOD-like receptor signaling pathway 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
93 | Non-alcoholic fatty liver disease (NAFLD) 3 genes, 4 drugs (DrugBank) and 30 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
94 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
95 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
96 | Osteoclast differentiation 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
97 | Oxytocin signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
98 | Pancreatic cancer 3 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
99 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
100 | Pathogenic Escherichia coli infection 11 genes, 4 drugs (DrugBank) and 21 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
101 | Pathways in cancer 6 genes, 8 drugs (DrugBank) and 58 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
102 | PD-L1 expression and PD-1 checkpoint pathway in cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
103 | Pertussis 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
104 | Phagosome 9 genes, 1 drug (DrugBank) and 4 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
105 | Phospholipase D signaling pathway 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
106 | PI3K-Akt signaling pathway 6 genes, 8 drugs (DrugBank) and 58 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
107 | Platinum drug resistance 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
2件: TOP2A, TOP2B |
D03899 |
Doxorubicin |
6件: 26, 28, 34, 61, 63, 331 |
D00125 |
Etoposide |
11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
D04107 |
108 | Prion diseases 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
109 | Propanoate metabolism 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
110 | Prostate cancer 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
111 | Proteasome 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: PSMB5 |
D03150 |
Bortezomib |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
112 | Proteoglycans in cancer 4 genes, 6 drugs (DrugBank) and 47 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
113 | Rap1 signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
114 | Ras signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
115 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
116 | Relaxin signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
117 | Renal cell carcinoma 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
118 | Rheumatoid arthritis 3 genes, 4 drugs (DrugBank) and 23 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
119 | RIG-I-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
120 | Salmonella infection 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
121 | Shigellosis 3 genes, 5 drugs (DrugBank) and 46 diseases shown |
1件: EGFR |
D03455 |
Cetuximab |
5件: 34, 51, 86, 89, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
122 | Sphingolipid signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
123 | Systemic lupus erythematosus 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
124 | T cell receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
125 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank) and 14 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
126 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
127 | Th17 cell differentiation 3 genes, 5 drugs (DrugBank) and 48 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
128 | Thermogenesis 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
129 | Thyroid hormone signaling pathway 1 gene, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
130 | TNF signaling pathway 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
131 | Toll-like receptor signaling pathway 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
132 | Toxoplasmosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
133 | Transcriptional misregulation in cancer 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D09669 |
Siltuximab |
2件: 28, 331 |
134 | Tuberculosis 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
135 | Type I diabetes mellitus 3 genes, 3 drugs (DrugBank) and 29 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
136 | Type II diabetes mellitus 3 genes, 5 drugs (DrugBank) and 53 diseases shown |
1件: CACNA1G |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
D06068 |
Temsirolimus |
4件: 13, 34, 89, 331 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
137 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
138 | VEGF signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
139 | Viral protein interaction with cytokine and cytokine receptor 3 genes, 4 drugs (DrugBank) and 30 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
140 | Yersinia infection 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: IL6 |
D09669 |
Siltuximab |
2件: 28, 331 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |